NMR studies probing the directionality of DNA interstrand cross-linking by the trinuclear platinum complex BBR3464

被引：1
|
作者：
Thomas, DS
Davies, MS
Zhang, JY
Berners-Price, SJ
Farrell, N
机构：
[1] Univ Western Australia, Sch Biomed & Chem Sci, Nedlands, WA 6009, Australia
[2] Virginia Commonwealth Univ, Dept Chem, Richmond, VA 23284 USA
来源：
JOURNAL OF INORGANIC BIOCHEMISTRY | 2003年 / 96卷 / 01期
关键词：
D O I：
10.1016/S0162-0134(03)80785-7
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：239 / 239
页数：1
相关论文
共 30 条
  • [1] NMR studies probing the origin of the unique antitumour activity of the new trinuclear platinum anticancer drug BBR3464
    Berners-Price, SJ
    Davies, MS
    Thomas, DS
    Hegmans, A
    Cox, JW
    Farrell, N
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2001, 86 (01) : 23 - 23
  • [2] Kinetic and equilibria studies of the aquation of the trinuclear platinum anticancer agent BBR3464
    Thomas, DS
    Davies, MS
    Hegmans, A
    Berners-Price, S
    Farrell, N
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2001, 86 (01) : 454 - 454
  • [3] DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464 - Conformation, recognition by high mobility group domain proteins, and nucleotide excision
    Kasparkova, J
    Zehnulova, J
    Farrell, N
    Brabec, V
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) : 48076 - 48086
  • [4] The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin
    Servidei, T
    Ferlini, C
    Riccardi, A
    Meco, D
    Scambia, G
    Segni, G
    Manzotti, C
    Riccardi, R
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (07) : 930 - 938
  • [5] A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464
    Tracey D. McGregor
    Alexander Hegmans
    Jana Kašpárková
    Kamila Neplechová
    Olga Nováková
    Hana Peňazová
    Oldrich Vrána
    Viktor Brabec
    Nicholas Farrell
    JBIC Journal of Biological Inorganic Chemistry, 2002, 7 : 397 - 404
  • [6] A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464
    McGregor, TD
    Hegmans, A
    Kaspárková, J
    Neplechová, K
    Nováková, O
    Penazová, H
    Vrána, O
    Brabec, V
    Farrell, N
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2002, 7 (4-5): : 397 - 404
  • [7] Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464
    Zehnulova, J
    Kasparkova, J
    Farrell, N
    Brabec, V
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) : 22191 - 22199
  • [8] Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin
    Kasparkova, J
    Fojta, M
    Farrell, N
    Brabec, V
    NUCLEIC ACIDS RESEARCH, 2004, 32 (18) : 5546 - 5552
  • [9] DNA Interstrand Cross-Links of an Antitumor Trinuclear Platinum(II) Complex: Thermodynamic Analysis and Chemical Probing
    Malina, Jaroslav
    Farrell, Nicholas P.
    Brabec, Viktor
    CHEMISTRY-AN ASIAN JOURNAL, 2011, 6 (06) : 1566 - 1574
  • [10] Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesopliageal adenocarcinoma
    Jodrell, DI
    Evans, TRJ
    Steward, W
    Cameron, D
    Prendiville, J
    Aschele, C
    Noberasco, C
    Lind, M
    Carmichael, J
    Dobbs, N
    Camboni, G
    Gatti, B
    De Braud, F
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (12) : 1872 - 1877
123